Dino Mehic/LinkedIn
Dec 14, 2025, 13:14
Dino Mehic with Colleagues: BDUC – What is It and What Do We Know?
Dino Mehic, Physician Scientist at the Medical University of Vienna, shared on LinkedIn:
“Bleeding Disorder of Unknown Cause (BDUC): What Do We Know?
- We are excited to share that we recently summarized nearly two decades of clinical and research experience in the management of patients with bleeding disorders of unknown cause (BDUC).
- This review represents a long-standing, collaborative effort to better understand the natural history of BDUC led by Ingrid Pabinger, Johanna Gebhart, and Cihan Ay at our institution (Medical University of Vienna).
- At the American Society of Hematology 2025 Annual Meeting in Orlando, Prof. Pabinger presented our current understanding of how to predict and treat BDUC-an important step toward improving care for this under-recognized patient population.
Title: Predictors for future bleeding in bleeding disorder of unknown cause
Authors: Tim Dreier, Dino Mehic, Cihan Ay, Johanna Gebhart, Ingrid Pabinger

Link to the publication in ASH Hematology”
Stay informed with ASH2025 updates on Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring